Glass House Brands Inc.
- Tickers
- GLAS
- Headquarters
- Not recorded
- SEC CIK
- 0001848731
- Website
- Not recorded
Closing prices
Latest close, 2.28
Prices start 30 Jun 2026.
| Date | Close |
|---|---|
| 13.00 | |
| 12.32 | |
| 12.50 | |
| 11.30 | |
| 11.56 | |
| 11.49 | |
| 11.61 | |
| 11.81 | |
| 11.41 | |
| 11.42 | |
| 11.02 | |
| 10.34 | |
| 10.79 | |
| 10.71 | |
| 10.73 | |
| 10.53 | |
| 10.04 | |
| 10.02 | |
| 10.12 | |
| 9.89 | |
| 9.41 | |
| 9.90 | |
| 9.53 | |
| 10.06 | |
| 10.07 | |
| 9.26 | |
| 9.68 | |
| 10.13 | |
| 10.01 | |
| 9.98 | |
| 10.29 | |
| 9.97 | |
| 9.41 | |
| 9.69 | |
| 9.36 | |
| 9.70 | |
| 9.52 | |
| 9.79 | |
| 9.88 | |
| 10.13 | |
| 10.40 | |
| 9.78 | |
| 9.88 | |
| 8.93 | |
| 8.49 | |
| 8.55 | |
| 8.60 | |
| 8.88 | |
| 8.36 | |
| 8.14 | |
| 7.98 | |
| 7.93 | |
| 8.10 | |
| 8.04 | |
| 8.03 | |
| 7.99 | |
| 7.97 | |
| 7.94 | |
| 8.01 | |
| 7.85 | |
| 7.15 | |
| 6.80 | |
| 6.85 | |
| 6.79 | |
| 5.61 | |
| 5.32 | |
| 5.49 | |
| 5.35 | |
| 5.16 | |
| 5.13 | |
| 4.41 | |
| 4.26 | |
| 4.08 | |
| 3.85 | |
| 3.69 | |
| 3.71 | |
| 3.19 | |
| 2.46 | |
| 2.34 | |
| 2.33 | |
| 2.28 | |
| 2.14 | |
| 2.14 | |
| 2.34 | |
| 2.25 | |
| 2.28 |
Drugs
No drugs from this company are tracked yet.
FDA-approved applications
No Drugs@FDA application has a sponsor name that matches this company.
Data provided by the U.S. Food and Drug Administration (Drugs@FDA). Sponsors are matched to companies by name; subsidiaries do not link.
Catalysts
No catalysts yet. Editors add each date together with its source.
Deals
No approved deals involve this company yet.
Reported fundamentals (SEC XBRL)
| Metric | Reported value | Period | Filing |
|---|---|---|---|
| Revenue | 181,984,000 USD | 1 Jan 2025 to 31 Dec 2025 FY2025 | 40-F for Revenue on sec.gov (opens in a new tab)Filed |
| Net income (loss) | −29,659,000 USD | 1 Jan 2025 to 31 Dec 2025 FY2025 | 40-F for Net income (loss) on sec.gov (opens in a new tab)Filed |
| Research and development expense | Not reported in XBRL filings since 2015 | ||
| Operating expenses | 93,493,000 USD | 1 Jan 2025 to 31 Dec 2025 FY2025 | 40-F for Operating expenses on sec.gov (opens in a new tab)Filed |
| Cash and cash equivalents | 23,350,000 USD | At 31 Dec 2025 FY2025 | 40-F for Cash and cash equivalents on sec.gov (opens in a new tab)Filed |
| Short-term investments and marketable securities | Not reported in XBRL filings since 2015 | ||
| Total liabilities | 143,955,000 USD | At 31 Dec 2025 FY2025 | 40-F for Total liabilities on sec.gov (opens in a new tab)Filed |
| Stockholders' equity | 73,936,000 USD | At 31 Dec 2025 FY2025 | 40-F for Stockholders' equity on sec.gov (opens in a new tab)Filed |
| Common shares outstanding (cover page) | Not reported in XBRL filings since 2015 | ||
History
| Period | Reported value | Filing |
|---|---|---|
| 1 Jan 2025 to 31 Dec 2025 FY2025 | 181,984,000 USD | 40-F filed 24 Mar 2026 on sec.gov (opens in a new tab)Filed |
| 1 Jan 2024 to 31 Dec 2024 FY2025 | 200,898,000 USD | 40-F filed 24 Mar 2026 on sec.gov (opens in a new tab)Filed |
| 1 Jan 2023 to 31 Dec 2023 FY2024 | 160,836,000 USD | 40-F filed 25 Mar 2025 on sec.gov (opens in a new tab)Filed |
| 1 Jan 2022 to 31 Dec 2022 FY2022 | 84,873,992 USD | 40-F/A filed 2 Apr 2024 on sec.gov (opens in a new tab)Filed |
| 1 Jan 2021 to 31 Dec 2021 FY2022 | 63,192,506 USD | 40-F/A filed 2 Apr 2024 on sec.gov (opens in a new tab)Filed |
| 1 Jan 2020 to 31 Dec 2020 FY2021 | 48,259,601 USD | 40-F/A filed 1 Apr 2022 on sec.gov (opens in a new tab)Filed |
Values as reported in the company's XBRL filings to the SEC, one per calendar period (SEC frames); not adjusted, not audited by HealthTrade, and not investment advice.
Source: SEC XBRL company facts (opens in a new tab) · Licence: public-domain · as of 2026-10-29 · read
SEC filings
Source: SEC EDGAR. Each row links to the filing on sec.gov.
Related news
No recent headlines mention this company.
Insider transactions
All rows for Glass House Brands Inc. on Insider TradesLast 90 days of Form 4 filings, from 3 Aug 2026 (US Eastern dates).
- Buys code P
- None in this period
- Sells code S
- 1 transaction, 3,818 shares, $30,658.54
- Other all other codes
- 4 transactions: grants, exercises, tax withholding, gifts and similar
Last transaction:
Insider filings are public records and are not a recommendation. Source: SEC EDGAR.
Sources
- Editor source (opens in a new tab) Licence: editorial. Entered by an editor, not fetched automatically
- SEC EDGAR submissions (opens in a new tab) Licence: public-domain. Fetched
Nothing on this page is investment advice.